These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 24247477

  • 1. Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats.
    De Carvalho CR, Pamplona FA, Cruz JS, Takahashi RN.
    Psychopharmacology (Berl); 2014 Apr; 231(7):1417-25. PubMed ID: 24247477
    [Abstract] [Full Text] [Related]

  • 2. Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice.
    Yu LL, Wang XY, Zhao M, Liu Y, Li YQ, Li FQ, Wang X, Xue YX, Lu L.
    Psychopharmacology (Berl); 2009 Jun; 204(2):203-11. PubMed ID: 19148622
    [Abstract] [Full Text] [Related]

  • 3. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B, Barthélémy S, Saurini F, Hamon M, Thiébot MH.
    Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
    [Abstract] [Full Text] [Related]

  • 4. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
    Hasanein P, Teimuri Far M.
    Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
    [Abstract] [Full Text] [Related]

  • 5. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B.
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [Abstract] [Full Text] [Related]

  • 6. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.
    Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
    [Abstract] [Full Text] [Related]

  • 7. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.
    Stern CAJ, da Silva TR, Raymundi AM, de Souza CP, Hiroaki-Sato VA, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ.
    Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696
    [Abstract] [Full Text] [Related]

  • 9. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
    Hampson RE, Miller F, Palchik G, Deadwyler SA.
    Neuropharmacology; 2011 May 01; 60(6):944-52. PubMed ID: 21288475
    [Abstract] [Full Text] [Related]

  • 10. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats.
    Forget B, Hamon M, Thiébot MH.
    Psychopharmacology (Berl); 2005 Oct 01; 181(4):722-34. PubMed ID: 15986197
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May 01; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 12. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
    Vimalanathan A, Gidyk DC, Diwan M, Gouveia FV, Lipsman N, Giacobbe P, Nobrega JN, Hamani C.
    Neuropharmacology; 2020 Apr 01; 166():107965. PubMed ID: 31962287
    [Abstract] [Full Text] [Related]

  • 13. Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats.
    Fang Q, Li FQ, Li YQ, Xue YX, He YY, Liu JF, Lu L, Wang JS.
    Pharmacol Biochem Behav; 2011 Oct 01; 99(4):738-42. PubMed ID: 21722663
    [Abstract] [Full Text] [Related]

  • 14. Bidirectional cannabinoid modulation of social behavior in adolescent rats.
    Trezza V, Vanderschuren LJ.
    Psychopharmacology (Berl); 2008 Apr 01; 197(2):217-27. PubMed ID: 18058088
    [Abstract] [Full Text] [Related]

  • 15. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar 01; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

  • 16. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
    Silva GB, Atchison DK, Juncos LI, García NH.
    Am J Physiol Renal Physiol; 2013 Feb 15; 304(4):F376-81. PubMed ID: 23220721
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
    Limebeer CL, Abdullah RA, Rock EM, Imhof E, Wang K, Lichtman AH, Parker LA.
    Psychopharmacology (Berl); 2014 Feb 15; 231(3):603-12. PubMed ID: 24043345
    [Abstract] [Full Text] [Related]

  • 18. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R.
    Psychopharmacology (Berl); 2008 Jul 15; 198(4):449-60. PubMed ID: 18446329
    [Abstract] [Full Text] [Related]

  • 19. Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints.
    Krustev E, Reid A, McDougall JJ.
    Arthritis Res Ther; 2014 Sep 27; 16(5):437. PubMed ID: 25260980
    [Abstract] [Full Text] [Related]

  • 20. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA, Saberi SA, Iyer V, Vemuri VK, Makriyannis A, Hohmann AG.
    J Pharmacol Exp Ther; 2018 Dec 27; 367(3):551-563. PubMed ID: 30275151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.